Company: ACADIA Pharmaceuticals Inc

More good news in the fight against lung cancer, reports CNBC's Mike Huckman

Irish pharma, United Drug posted a 12% rise in full-year earnings, but warned that the outlook was tougher and that sterling weakness could ...

After Wednesday's widespread selloff, Alain Schibl from Duet Asset Management sees US markets retesting the 2002 lows shortly. Fergus O'Sull...

Jigar Shah, senior VP & Head of Research, Kim Eng India tells CNBC's Oriel Morrison he is bullish on India's pharmaceuticals and telecom sec...

Snap-On Inc. CEO Nicholas Pinchuk shares his thoughts on a possible auto bailout with CNBC's Melissa Francis.

Discussing his choice of shareholders vote on his salary, with Daniel Amos, Aflac Inc. chairman/CEO

John Alfred Paulson, Paulson & Co., Inc. president testifies about the risks that hedge funds pose in the financial markets, before the Hous...

Test results show that Merck's Gardasil which is approved for young women also holds promise for men, with CNBC's Mike Huckman.

If the dollar continues to strengthen, it could take the tailwind out of U.S. MNCs, says Bob Doll, CIO of global equities at BlackRock. So w...

"I don't see a rally until the middle part of next year at the earliest," Neil Michael from SPA ETF, told CNBC. Michael recommends staying w...

Insight on whether the biotech sector could see a bounce on a new study, with CNBC's Mike Huckman and the Fast Money team.

Shares in AstraZeneca traded higher Monday after a study showed the use of its popular Statin Crestor could potentially be expanded dramatic...

A new study shoes Astra-Zeneca's pill Crestor can help prevent heart attacks among people with low cholesterol, reports CNBC's Mike Huckman

A new medical study could result in millions of Americans being put on a cholesterol-lowering drug, reports CNBC's Mike Huckman

POPULAR TAGS

TOPICS

Data is a real-time snapshot *Data is delayed at least 15 minutes